SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026201
Filing Date
2021-11-10
Accepted
2021-11-10 17:12:05
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20210930_10q.htm   iXBRL 10-Q 2471099
2 EXHIBIT 31.1 ex_285352.htm EX-31.1 14668
3 EXHIBIT 31.2 ex_285353.htm EX-31.2 14751
4 EXHIBIT 32.1 ex_285354.htm EX-32.1 7105
5 EXHIBIT 32.2 ex_285355.htm EX-32.2 7377
  Complete submission text file 0001437749-21-026201.txt   9132048

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kmph-20210930.xsd EX-101.SCH 73042
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20210930_cal.xml EX-101.CAL 46612
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20210930_def.xml EX-101.DEF 471378
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20210930_lab.xml EX-101.LAB 421434
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20210930_pre.xml EX-101.PRE 492757
11 EXTRACTED XBRL INSTANCE DOCUMENT kmph20210930_10q_htm.xml XML 1578864
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 211397756
SIC: 2834 Pharmaceutical Preparations